These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2741652)

  • 41. Transient stomatocytosis with hemolysis: a previously unrecognized complication of alcoholism.
    Douglass CC; Twomey JJ
    Ann Intern Med; 1970 Feb; 72(2):159-64. PubMed ID: 5412483
    [No Abstract]   [Full Text] [Related]  

  • 42. Acquired stomatocytosis in alcoholic liver disease.
    Wislöff F; Boman D
    Scand J Haematol; 1979 Jul; 23(1):43-50. PubMed ID: 493871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience.
    Batra A; Patel B; Addison D; Baldassarre LA; Desai N; Weintraub N; Deswal A; Hussain Z; Brown SA; Ganatra S; Agarwala V; Parikh PM; Fradley M; Ghosh A; Guha A
    Open Heart; 2021 Dec; 8(2):. PubMed ID: 34952868
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is lithium able to reverse neurological damage induced by vinca alkaloids? (Short communication).
    Petrini M; Vaglini F; Cervetti G; Cavalletti M; Sartucci F; Murri L; Corsini GU
    J Neural Transm (Vienna); 1999; 106(5-6):569-75. PubMed ID: 10443559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vocal fold palsy following vinca alkaloid treatment.
    Burns BV; Shotton JC
    J Laryngol Otol; 1998 May; 112(5):485-7. PubMed ID: 9747483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostaglandin F2 alpha in the treatment of vinca alkaloid-induced ileus.
    Saito H; Yamamoto T; Kimura M; Shimokata K
    Am J Med; 1993 Nov; 95(5):549-51. PubMed ID: 8238076
    [No Abstract]   [Full Text] [Related]  

  • 47. Current developments in antitumor antibiotics, epipodophyllotoxins, and vinca alkaloids.
    Rowinsky EK
    Curr Opin Oncol; 1991 Dec; 3(6):1060-9. PubMed ID: 1843108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hemolytic syndromes in the course of malignant blood diseases. Study of tests of erythrocytic agglutination in the course of these conditions].
    BOUSSER J; PEAN G
    Sem Hop; 1959 Sep 18-28; 35():2578-80. PubMed ID: 13803383
    [No Abstract]   [Full Text] [Related]  

  • 49. Hemolytic anemia in protoporphyria: possible precipitating role of liver failure and photic stress.
    Key NS; Rank JM; Freese D; Bloomer JR; Hammerschmidt DE
    Am J Hematol; 1992 Mar; 39(3):202-7. PubMed ID: 1546716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On the elucidation of the mechanism of Vinca alkaloid fluorination in superacidic medium.
    Giovanelli E; Leroux S; Moisan L; Carreyre H; Thuéry P; Buisson DA; Meddour A; Coustard JM; Thibaudeau S; Rousseau B; Nicolas M; Hellier P; Doris E
    Org Lett; 2011 Aug; 13(15):4116-9. PubMed ID: 21732596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Bladder hyporeflexia caused by vinca alkaloids].
    Pérez Pérez J; Richart López A; González Enguita C; Cabrera Pérez J; Bernacer Borja M; Vela Navarrete R
    Actas Urol Esp; 2000 Mar; 24(3):275-7. PubMed ID: 10870240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Are vinca alkaloids associated with myocardial infarction?
    Kantor AF; Greene MH; Boice JD; Fraumeni JF; Flannery JT
    Lancet; 1981 May; 1(8229):1111. PubMed ID: 6112479
    [No Abstract]   [Full Text] [Related]  

  • 53. Stomatocytosis in a Beagle and Australian Cattle Dog.
    Castillo D; Williams TL
    Vet Clin Pathol; 2021 Dec; 50(4):501-506. PubMed ID: 34628677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Significance of autohemolysis of erythrocytes in the diagnosis of hemolytic diseases].
    Urasiński I
    Pol Arch Med Wewn; 1965; 35(10):1485-91. PubMed ID: 5861181
    [No Abstract]   [Full Text] [Related]  

  • 55. Hyaluronidase as an antidote to extravasation of Vinca alkaloids: clinical results.
    Bertelli G; Dini D; Forno GB; Gozza A; Silvestro S; Venturini M; Rosso R; Pronzato P
    J Cancer Res Clin Oncol; 1994; 120(8):505-6. PubMed ID: 8207052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Labeling Changes for Vinca Alkaloid Chemotherapies.
    Aschenbrenner DS
    Am J Nurs; 2021 May; 121(5):25. PubMed ID: 33872259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malignant hypertension and red cell fragmentation syndrome. Report of a case.
    Capelli JP; Wesson GL; Erslev AV
    Ann Intern Med; 1966 Jan; 64(1):128-36. PubMed ID: 5900775
    [No Abstract]   [Full Text] [Related]  

  • 58. Acquired stomatocytosis: its prevalence of significance in routine haematology.
    Davidson RJ; How J; Lessels S
    Scand J Haematol; 1977 Jul; 19(1):47-53. PubMed ID: 882841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pharmacological studies on Vinca herbacea W.K. alkaloids. I].
    RUSINOV K; ZHELIAZKOVD ; GEORGIEVV
    Izv Inst Fiziol (Sofiia); 1962; 5():271-306. PubMed ID: 14495363
    [No Abstract]   [Full Text] [Related]  

  • 60. Hematologic toxicity of drugs used in cardiovascular disease.
    Missri J
    Postgrad Med; 1979 Jan; 65(1):165-8, 171-2. PubMed ID: 104288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.